Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway

Atherosclerosis. 2002 Jan;160(1):115-22. doi: 10.1016/s0021-9150(01)00574-3.

Abstract

We examined whether acute in vivo increases in either plasma glucose or insulin concentrations stimulate PAI-1 gene expression in fat tissue. We studied chronically catheterized unstressed and awake, lean (approximately 300 g, n=12) and obese (approximately 450 g, n=12) Sprague-Dawley rats. Hyperglycemia (approximately 18mM) was induced for 3 h by glucose infusion during a pancreatic clamp (somatostatin inhibited endogenous insulin secretion). Compared with equivalent saline infusion, hyperglycemia induced a 6-7 fold increase in PAI-1 gene expression in both lean and obese rats (P<0.001). When the rate of cellular glucose uptake was matched during a euglycemic hyperinsulinemic (approximately 60 microU/ml) clamp, PAI-1 gene expression in both obese and lean rats was proportionately and significantly increased (P<0.001). We further examined whether induction of the hexosamine biosynthetic pathway would mimic the effects of hyperglycemia and hyperinsulinemia on PAI-1 gene expression. Indeed, infusion of glucosamine (GlcN, 30 micromol/kg/min), induced a approximately 3-4 fold increase (P<0.01) in PAI-1 gene expression in both lean and obese animals. While obese rats had a four times greater fat mass then the lean rats, PAI-1 gene expression remained significantly higher when expressed as per gram fat. Our results support the hypothesis that increased glucose uptake induces PAI-1 gene expression in adipose tissue, probably through the activation of the hexosamine biosynthetic pathway. These findings may account for some of the fibrinolytic alterations seen in obese type 2 diabetic humans.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adipose Tissue / metabolism*
  • Animals
  • Biotransformation / drug effects*
  • Blood Glucose / analysis
  • Blood Glucose / drug effects
  • Body Composition / drug effects
  • Body Weight / drug effects
  • Gene Expression Regulation / drug effects*
  • Glucosamine / pharmacokinetics
  • Hexosamines / biosynthesis*
  • Hyperglycemia / metabolism*
  • Insulin / blood
  • Insulin Resistance
  • Male
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Chloride / pharmacokinetics

Substances

  • Blood Glucose
  • Hexosamines
  • Insulin
  • Plasminogen Activator Inhibitor 1
  • Sodium Chloride
  • Glucosamine